Evidence-Based Complementary and Alternative Medicine / 2014 / Article / Tab 2 / Research Article
Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study Table 2 Numbers of patients who were exposed to different mistletoe preparations and adverse drug reactions that occurred.
Preparation Patients ADRs* Relative frequency of ADRs (%)# Types of ADRs Abnoba viscum (n.s.) 2 Abnoba viscum Abietis 15 Abnoba viscum Aceris 2 Abnoba viscum Amygdali 2 Abnoba viscum Crataegi 1 Abnoba viscum Fraxini 133 7 (10) 5.3 Local reaction × 2, pruritus × 2, urticaria × 2, pyrexia, myalgia, hypoaesthesia oral, paraesthesia Abnoba viscum Mali 2 Abnoba viscum Pini 4 Abnoba viscum Quercus 7 1 (1) 14.3 Rash Total Abnoba viscum 161 8 (11) 5.0 Helixor (n.s.) 5 0 Helixor Abietis 106 2 (2) 2.8 Urticaria, pruritus Helixor Mali 187 8 (12) 4.3 Pyrexia × 5, pruritus × 2, fatigue, infusion site inflammation, headache, hypersensitivity × 2 Helixor Pini 51 Total Helixor 321 10 (15) 3.1 Iscador (n.s.) 4 Iscador Mali 8
1 (2) 12.5 Pyrexia × 2 Iscador Mali c. Arg. 1 Iscador Mali special 8 2 (3) 25.0 Pyrexia, vomiting, chills Iscador Pini 2 Iscador Quercus 9 1 (1) 11.1 Pyrexia Iscador Quercus special 8 Iscador Ulmi c. Hg 2 Total Iscador 40 4 (6) 10.0 Total 475 22 4.6
Number of patients to have an ADR followed by the total number of ADRs in brackets.
# Percentage of patients exposed to that preparation type who had an ADR. n.s.: not specified.